Recently, Chu et al. demonstrated the cytotoxic activity of anti-ROR1 CAR NK cells in combination with an IL-15 superagonist (N-803) against NB cell lines and the ability of this therapy to induce tumor control and enhance survival in NB mice models. This evidence concerns the gene IL15 and neuroblastoma.